Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Change in Inventory (2016 - 2025)

Haemonetics (HAE) has 17 years of Change in Inventory data on record, last reported at -$13.8 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 179.86% year-over-year to -$13.8 million; the TTM value through Dec 2025 reached -$38.5 million, down 146.05%, while the annual FY2025 figure was $64.7 million, 7.73% up from the prior year.
  • Change in Inventory reached -$13.8 million in Q4 2025 per HAE's latest filing, up from -$21.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $36.2 million in Q2 2024 and bottomed at -$21.8 million in Q3 2025.
  • Average Change in Inventory over 5 years is $1.8 million, with a median of $1.4 million recorded in 2022.
  • Peak YoY movement for Change in Inventory: crashed 574.14% in 2022, then soared 756.92% in 2024.
  • A 5-year view of Change in Inventory shows it stood at -$3.1 million in 2021, then skyrocketed by 148.21% to $1.5 million in 2022, then skyrocketed by 578.37% to $10.1 million in 2023, then skyrocketed by 72.17% to $17.3 million in 2024, then tumbled by 179.86% to -$13.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$13.8 million in Q4 2025, -$21.8 million in Q3 2025, and -$3.3 million in Q2 2025.